AI assistant
Sending…
IMPACT BIOMEDICAL INC. — Director's Dealing 2024
Dec 4, 2024
35295_dirs_2024-12-03_7c23e388-0c58-4a14-bc9e-0ed5a88f0a0c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMPACT BIOMEDICAL INC. (IBO)
CIK: 0001834105
Period of Report: 2024-11-27
Reporting Person: Heuszel Frank D (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-27 | Common Stock | P | 500 | $2.61 | Acquired | 96844 | Direct |
More from IMPACT BIOMEDICAL INC.
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 6
Director's Dealing
2026
Mar 26
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Jan 6
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 11
Interim / Quarterly Report
2025
Nov 7
Regulatory Filings
2025
Nov 6
Regulatory Filings
2025
Oct 27